Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 05 Apr 2022 for Genocea Biosciences, INC., €1,242. Read the official filing
Filing timeline
BuySaleThomas Andrew Davis
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Thomas Andrew Davis: trading record in brief
This profile gathers the share dealings of Thomas Andrew Davis in Genocea Biosciences, Inc., where the filings describe the role as senior executive. We count 2 filings; the first trade dates from 15 March 2022 and the latest from 4 April 2022.
The open-market record consists of 1 sale worth €1,242, with no purchase. Outside the open market, there are 1 share grant.
The newest entry dates from 5 April 2022: an open-market sale of €1,242, in Genocea Biosciences, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Andrew Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,091 shares@ US$1.25100.0% of flowCommon StockSEC:0001457612-22-000044:0
31,250 shares0Common StockSEC:0001457612-22-000028:0
2 of 2 declarations
